TXNDC9 has not been functionally characterized in ALL or in lymphocytes, but thioredoxins are known to carry out diverse functions in regulating both the proteasome and redox metabolism, therefore further exploration, and characterization of TXNDC9 could reveal lineage-related differences and biological dependencies and thus therapeutic implications of this protein. This evidence concerns the gene TXN and acute lymphoblastic leukemia.